- Home
- BMRN vs WAL Comparison
BMRN vs WAL Comparison
Compare BMRN & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- WAL
- Stock Information
- Founded
- BMRN 1996
- WAL 1994
- Country
- BMRN United States
- WAL United States
- Employees
- BMRN N/A
- WAL N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- WAL Major Banks
- Sector
- BMRN Health Care
- WAL Finance
- Exchange
- BMRN Nasdaq
- WAL Nasdaq
- Market Cap
- BMRN 10.0B
- WAL 8.5B
- IPO Year
- BMRN 1999
- WAL 2005
- Fundamental
- Price
- BMRN $51.52
- WAL $79.58
- Analyst Decision
- BMRN Buy
- WAL Strong Buy
- Analyst Count
- BMRN 19
- WAL 14
- Target Price
- BMRN $90.26
- WAL $98.57
- AVG Volume (30 Days)
- BMRN 2.9M
- WAL 1.7M
- Earning Date
- BMRN 10-27-2025
- WAL 10-21-2025
- Dividend Yield
- BMRN N/A
- WAL 1.90%
- EPS Growth
- BMRN 59.53
- WAL 24.99
- EPS
- BMRN 2.68
- WAL 8.09
- Revenue
- BMRN $3,094,001,000.00
- WAL $3,189,400,000.00
- Revenue This Year
- BMRN $13.32
- WAL $16.31
- Revenue Next Year
- BMRN $7.51
- WAL $9.04
- P/E Ratio
- BMRN $19.20
- WAL $9.89
- Revenue Growth
- BMRN 12.39
- WAL 9.57
- 52 Week Low
- BMRN $50.76
- WAL $57.05
- 52 Week High
- BMRN $73.51
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- BMRN 40.53
- WAL 49.56
- Support Level
- BMRN $51.80
- WAL $75.02
- Resistance Level
- BMRN $53.49
- WAL $79.59
- Average True Range (ATR)
- BMRN 1.84
- WAL 2.20
- MACD
- BMRN -0.08
- WAL 0.56
- Stochastic Oscillator
- BMRN 12.58
- WAL 77.64
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.